Kinaxis (TSE:KXS – Get Free Report) released its quarterly earnings data on Wednesday. The company reported C$1.72 earnings per share for the quarter, FiscalAI reports. The company had revenue of C$228.16 million for the quarter. Kinaxis had a return on equity of 20.88% and a net margin of 14.40%.
Kinaxis Stock Up 3.5%
KXS stock opened at C$204.61 on Friday. Kinaxis has a one year low of C$117.22 and a one year high of C$205.00. The firm has a market cap of C$5.56 billion, a PE ratio of 66.87, a PEG ratio of 3.60 and a beta of 0.43. The firm’s 50 day moving average price is C$182.19 and its 200-day moving average price is C$156.30. The company has a debt-to-equity ratio of 11.14, a quick ratio of 2.29 and a current ratio of 1.88.
Analysts Set New Price Targets
A number of analysts have issued reports on the company. National Bank Financial raised their target price on Kinaxis from C$200.00 to C$210.00 and gave the stock an “outperform” rating in a research note on Friday, August 7th. RBC Dominion Securities set a C$210.00 price target on shares of Kinaxis and gave the company an “outperform” rating in a research report on Friday, October 23rd. BMO Capital Markets boosted their price target on shares of Kinaxis from C$195.00 to C$200.00 and gave the company an “outperform” rating in a research report on Friday, August 7th. Royal Bank Of Canada set a C$210.00 price objective on shares of Kinaxis and gave the company an “outperform” rating in a report on Wednesday, August 26th. Finally, Stifel Nicolaus raised their price objective on shares of Kinaxis from C$200.00 to C$225.00 and gave the stock a “buy” rating in a research report on Thursday, October 29th. Eight research analysts have rated the stock with a Buy rating. Based on data from MarketBeat, Kinaxis presently has an average rating of “Buy” and a consensus target price of C$206.67.
Read Our Latest Stock Report on KXS
Insider Buying and Selling
In related news, Director Gillian H. (Jill) Denham sold 15,968 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of C$171.36, for a total value of C$2,736,276.48. Following the completion of the transaction, the director directly owned 18,732 shares in the company, valued at approximately C$3,209,915.52. This represents a 46.02% decrease in their ownership of the stock. Also, Director Robert G. Courteau sold 5,362 shares of the firm’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of C$178.39, for a total value of C$956,527.18. Following the sale, the director directly owned 37,898 shares of the company’s stock, valued at approximately C$6,760,624.22. This trade represents a 12.39% decrease in their position. Insiders sold a total of 33,730 shares of company stock valued at $5,877,368 in the last ninety days. Company insiders own 1.20% of the company’s stock.
Kinaxis Company Profile
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.
Read More
- Five stocks we like better than Kinaxis
- These 3 Underperforming Stocks Are Seeing Notable CEO Insider Trades
- GE Aerospace Has a $170 Billion Backlog, But Is the Stock Worth the Premium?
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.
